To view the PDF file, sign up for a MySharenet subscription.

DSY - Discovery Holdings Limited - Trading statement for the nine months ended

Release Date: 24/06/2011 10:30
Code(s): DSY
Wrap Text

DSY - Discovery Holdings Limited - Trading statement for the nine months ended 31 March 2011 DISCOVERY HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number: 1999/007789/06) ISIN: ZAE000022331 Share Code: DSY ("Discovery" or "the Company") TRADING STATEMENT FOR THE NINE MONTHS ENDED 31 MARCH 2011 Introduction Discovery`s strong performance during the interim financial reporting period to 31 December 2010 continued over the first quarter of the 2011 calendar year, with all operating entities performing in line with expectation. During the period, Discovery continued to make significant progress towards achieving its stated strategic objectives, being the attainment of quality growth in its South African businesses; scale, profitability and relevance in its international business; and launching new businesses that leverage the unique presence and footprint of Discovery in South Africa. On the basis of the current performance, and recognising the effect of the accounting entries relating to the acquisition of Standard Life Healthcare, earnings per share for the financial year to June 2011 are expected to be at least 20% higher than that reported during the 2010 financial year. In addition, on a normalised basis - which adjusts for the effect of transactions related to the Standard Life Healthcare acquisition, and therefore provides a more accurate measure of the operating performance of the Group - normalised headline earnings per share are also expected to show an improvement of more than 20% over the prior period. Shareholders are further referred to the SENS announcement dated 24 June 2011 in which they were advised that Discovery intends to introduce a new class of equity capital. The new class of capital, being non-cumulative, non- participating, non-convertible, perpetual preference shares, will support the current strong growth in Discovery`s existing businesses, as well as make available efficient capital for emerging strategic opportunities. The forecast financial information on which this trading statement is based has not been reviewed and reported on by the Company`s external auditors. Group overview and operational highlights South African operations The strong performance of Discovery`s South African businesses, being Discovery Health, Discovery Life, Discovery Invest, Vitality and DiscoveryCard, continued over the first quarter of 2011, with a continuing focus on attracting and retaining select, high-quality members, ongoing product development, and the realisation of incremental operating efficiencies across the business. Specific highlights by business include: - Discovery Health: Total medical scheme membership surpassed the 2.5 million lives level, with ongoing low lapse levels. In the context of the acquisition of a number of large closed schemes in the comparative period, new business growth remained strong. - Discovery Life: Risk new business (excluding ACI`s) for the 9-month period grew at similar rates to those achieved during the first 6-months, with mortality and morbidity experience performing better than expected, and lapses tracking in line with assumption. - Discovery Invest: Retail Assets under Management reached R16.5bn during June 2011, with continued beneficial asset mix and excellent fund performance. In addition to the performance of the existing businesses, the period under review also saw the launch of Discovery Insure, Discovery`s entry into the short-term insurance market. Discovery Insure is the next manifestation of the Discovery model, and is complementary to Discovery`s existing businesses. Initial interest in the Discovery Insure offering has been high, and above expectation. International operations Discovery continues to pursue two distinct strategies internationally; first, a focus on achieving scale, relevance and profitability in the UK with PruHealth and PruProtect, and second, operationalising the joint ventures in China and the US with Ping An Group of China and Humana Inc., respectively. Specific highlights of the international operations include: - PruHealth: Intense focus has been applied to the management of the loss ratio, lapse rate and expense levels over the period. Further progress has been made in integrating the former PruHealth and Standard Life Healthcare businesses in the key areas of people, systems, service and product. - PruProtect: PruProtect delivered a strong operating performance for the 9- month period across the dimensions of new business, claims and expenses. - The Vitality Group: Work continues to operationalise HumanaVitality, the joint venture with Humana, for a launch during the second half of calendar 2011. From a stand-alone Vitality perspective, The Vitality Group continues to develop a pipeline of activity, and will leverage the additional capital received from the Humana transaction, as well as the scale of Humana in the US, to significantly enhance the wellness and reward components of its program. - Ping An Health: The current focus has been on transferring the Discovery Health IP to China, and making the systems and protocols fit for purpose for Ping An Health. From a product perspective, significant work has taken place to tailor the Discovery capabilities to the Chinese market, with a view to a number of small product launches towards the end of 2011, and into 2012. Sandton 24 June 2011 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 24/06/2011 10:30:01 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story